Research
All Research Featured Research
Perspective
Middlemen, Not Drug Companies, Are Pushing Up Insulin Prices, and Congress Doesn’t Have the Right Plan to Fight Back
November 19, 2021
Featured Experts: Karen Van Nuys, PhD, Neeraj Sood, PhD
Journal Article
Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018
November 5, 2021
Featured Experts: Karen Van Nuys, PhD, Neeraj Sood, PhD
News
More than Half of Insulin Expenditures Going to Middlemen, New USC Schaeffer Study Finds
November 5, 2021
Featured Experts: Karen Van Nuys, PhD, Neeraj Sood, PhD
Data Visualization
Untangling the Price of Insulin
November 5, 2021
Featured Experts: Karen Van Nuys, PhD, Neeraj Sood, PhD
Journal Article
Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members
July 7, 2021
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD, Geoffrey Joyce, PhD
Journal Article
Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
May 7, 2021
Featured Experts: Darius Lakdawalla, PhD
Perspective
Insurer Formularies Complicate the Adoption of Biosimilar Cancer Therapies
April 8, 2021
Featured Experts: Alice Chen, PhD, Karen Van Nuys, PhD
Journal Article
Do Companies in the Pharmaceutical Supply Chain Earn Excess Returns?
January 4, 2021
Featured Experts: Neeraj Sood, PhD, Karen Mulligan, PhD
Journal Article
Variation in Generic Dispensing Rates in Medicare Part D
November 13, 2020
Featured Experts: Geoffrey Joyce, PhD
Perspective
Sharing Drug Rebates With Medicare Part D Patients: Why And How
September 15, 2020
Featured Experts: Steven M. Lieberman, MPhil, MA, Paul Ginsburg, PhD, Erin Trish, PhD
News
Drug Cost-Sharing Based on Net Price Benefits Medicare Part D Patients
March 17, 2020
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
White Paper
How Would Sharing Rebates at the Point-Of-Sale Affect Beneficiary Cost-Sharing in Medicare Part D?
March 17, 2020
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
News
New Evidence Shows Prescription Drug Rebates Play a Role in Increasing List Prices
February 11, 2020
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
White Paper
The Association Between Drug Rebates and List Prices
February 11, 2020
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
Perspective
Who Pays in Medicare Part D? Giving Plans More Skin in the Game
November 20, 2019
Featured Experts: Erin Trish, PhD, Paul Ginsburg, PhD, Geoffrey Joyce, PhD, Dana Goldman, PhD
Perspective
It’s Hard to Lower Drug Prices, If You Don’t Know What They Are
October 21, 2019
Featured Experts: Neeraj Sood, PhD
Journal Article
Analysis of State-Level Drug Pricing Transparency Laws in the United States
September 25, 2019
Featured Experts: Neeraj Sood, PhD
News
Most State Laws Aimed at Improving Drug Pricing Transparency Won’t Help, According to New Study
September 25, 2019
Featured Experts: Neeraj Sood, PhD
White Paper
State Drug Pricing Transparency Laws: Numerous Efforts, Most Fall Short
September 25, 2019
Featured Experts: Neeraj Sood, PhD